Indications for HSCT Autologous HSCT accounts for 58％ of the transplantations done in Europe today;47％ of the autologous HSCT are performed for multiple myeloma.30％ for non-Hodgkin lymphoma,11％ for Hodgkin lymphom...
Indications for HSCT Autologous HSCT accounts for 58％ of the transplantations done in Europe today;47％ of the autologous HSCT are performed for multiple myeloma.30％ for non-Hodgkin lymphoma,11％ for Hodgkin lymphoma,3％ for *** less common indications for autologous HSCT include autoimmune disease (multiple sclerosis, systemic sclerosis, and Crohn's disease) and solid tumors (sarcoma, germinal tumors, and neuro-blastoma)
暂无评论